Expression of concern to “Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition” [Biomed. Pharmacother. 177 (2024) 117023] - 17/04/26

Xinyu Li ^{a, b, c}, Hui Li ^{a, b, c}, Bo Feng ^{a, b, c}, Xiaoyan Chen ^d, Ting Chen ^{a, b, c}, Jiafei Lu ^{a, b, c}, Huating Xie ^{a, b, c}, Nana Su ^{a, b, c}, Houlin Chen ^{a, b, c}, Chenghao Lou ^{a, b, c}, Runxin Zhuang ^{b, c}, Xi Chen ^{a, b, c}, Shengwei Jin ^{a, b, c, ⁎} , Yu Hao ^{a, b, c, e, ⁎}

^a Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, China 

^b Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou 325000, China 

^c Key Laboratory of Anesthesiology of Zhejiang Province, Wenzhou Medical University, Wenzhou 325000, China 

^d Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 

^e Wenzhou Key Laboratory of Precision General Practice and Health Management, Wenzhou 325000, China 

^⁎ Corresponding authors at: Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, China. Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University Wenzhou 325000 China

Le texte complet de cet article est disponible en PDF.